miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies
Authors
Keywords
BCL-xL, BCL-2 family gene expression, Chronic lymphocytic leukemia, micro-RNA, miR-377, 14q32 miRNA cluster
Journal
Molecular Cancer
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-04
DOI
10.1186/s12943-015-0460-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BH3 Inhibitor Sensitivity and Bcl-2 Dependence in Primary Acute Lymphoblastic Leukemia Cells
- (2015) S. E. Alford et al. CANCER RESEARCH
- MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma
- (2015) Liron Zehavi et al. Molecular Cancer
- MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
- (2015) G S Choudhary et al. Cell Death & Disease
- Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia
- (2014) Floriana Manodoro et al. BLOOD
- A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects inTP53
- (2014) Polina Shindiapina et al. BRITISH JOURNAL OF HAEMATOLOGY
- A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma
- (2014) E. Nadal et al. CLINICAL CANCER RESEARCH
- 14q deletions are associated with trisomy 12,NOTCH1mutations and unmutatedIGHVgenes in chronic lymphocytic leukemia and small lymphocytic lymphoma
- (2014) Adrien Cosson et al. GENES CHROMOSOMES & CANCER
- Recurrent mutations refine prognosis in chronic lymphocytic leukemia
- (2014) P Baliakas et al. LEUKEMIA
- Kinase inhibitors overachieve in CLL
- (2014) Ken Garber NATURE REVIEWS DRUG DISCOVERY
- CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia
- (2013) Ye Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Control of metastatic progression by microRNA regulatory networks
- (2013) Nora Pencheva et al. NATURE CELL BIOLOGY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells
- (2013) A Formosa et al. ONCOGENE
- Chemical Genomics Identifies Small-Molecule MCL1 Repressors and BCL-xL as a Predictor of MCL1 Dependency
- (2012) Guo Wei et al. CANCER CELL
- Mcl-1 Phosphorylation Defines ABT-737 Resistance That Can Be Overcome by Increased NOXA Expression in Leukemic B cells
- (2012) S. Mazumder et al. CANCER RESEARCH
- MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer
- (2012) Yan Lu et al. CARCINOGENESIS
- Lymphoid malignancies: many tumor types, many altered genes, many therapeutic challenges
- (2012) Riccardo Dalla-Favera JOURNAL OF CLINICAL INVESTIGATION
- Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
- (2012) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial
- (2012) Sebastian Böttcher et al. JOURNAL OF CLINICAL ONCOLOGY
- An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737
- (2011) S. Al-harbi et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- (2011) Maria Angelica Cortez et al. Nature Reviews Clinical Oncology
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
- (2011) T. N. Chonghaile et al. SCIENCE
- Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms
- (2010) Lena Reindl et al. BRITISH JOURNAL OF HAEMATOLOGY
- miR 488* inhibits androgen receptor expression in prostate carcinoma cells
- (2010) Kavleen Sikand et al. INTERNATIONAL JOURNAL OF CANCER
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
- (2008) C. Pepper et al. BLOOD
- Prognostic markers in chronic lymphocytic leukemia: A comprehensive review
- (2008) Femke Van Bockstaele et al. BLOOD REVIEWS
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started